0 items USD 0.00Search
Your search for "globaldata b cell non hodgkin lymphoma global clinical trials review h2 2018" gave back 84109 results.
Publisher' newest research report, the “Lymphoma Treatment Drug Industry Forecast” looks at past sales and reviews total world Lymphoma...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Nivolumab Injection is suitable for treating adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are negative...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of the subtypes of T-cell lymphoma. Highlights The global...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of the subtypes of T-cell lymphoma. Highlights The global...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global CAR-T Cell Therapy market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
According to our Publisher latest study, the global CAR-T Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Bleomycin is an anti-cancer medicine used to treat certain forms of cancer of the head or the neck, cervix (the neck of the womb) and external sexual...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of the subtypes of T-cell lymphoma. Highlights The global...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Rituxan (Rituximab) and Biosimilar market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Rituxan (Rituximab) Monoclonal Antibody market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Adcetris is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Brentuximab vedotin is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Bone marrow transplantation, also referred as hematopoietic stem cell transplantation is the process of replacing diseased or damaged bone marrow or...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
